MDCX Medicus Pharma Ltd.
Nasdaq · SEC CIK 1997296 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 57 since 2025-05-21, latest 2026-09-08 17:02
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Brennan Edward J. | CSO | — | — |
| Mehmud Faisal | Chief Medical Off | — | — |
| Bonner Carolyn F. | Pres, CFO | — | — |
| Bokhari Raza | CEO, Dir | — | — |
| Smith Andrew Alasdair | COO | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-08 17:02 | 2026-09-04 | MDCX | Smith Andrew Alasdair | COO | A - Grant | $0.1705 | +735.3K | 735.5K | +448,350% | +$125.4K |
| D | 2026-09-08 17:01 | 2026-09-04 | MDCX | Mehmud Faisal | Chief Medical Off | A - Grant | $0.1705 | +1.47M | 1.47M | New | +$250.7K |
| D | 2026-09-08 17:01 | 2026-09-04 | MDCX | Brennan Edward J. | CSO | A - Grant | $0.1705 | +588.2K | 674.7K | +680% | +$100.3K |
| D | 2026-09-08 17:00 | 2026-09-04 | MDCX | Bonner Carolyn F. | Pres, CFO | A - Grant | $0.1705 | +1.47M | 1.49M | +7,779% | +$250.7K |
| D | 2026-09-08 17:00 | 2026-09-04 | MDCX | Bokhari Raza | CEO, Dir | A - Grant | $0.1705 | +2.94M | 2.94M | New | +$501.5K |
| DM | 2025-08-14 | 2025-08-13 | MDCX | Quinlan James P. | CFO | M - OptEx | $1.08 | +145.0K | 274.1K | +112% | +$156.2K |
| I | 2025-05-21 | 2025-05-20 | MDCX | Melani Kenneth R. | 10% | S - Sale | $7.72 | -75.0K | 3.25M | -2% | -$579.0K |
Purchase Sale Sale after option exercise All abbreviations